# Q&A with Scott Mazza, Founder of Vitality CBD | citybiz > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/vitality-cbd-founder-interview-cbd-product-quality/ > **Published:** 2026-04-21T08:03:28-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:35:49-04:00 > **Clinical Summary:** Explore the vitality cbd founder interview revealing insights on CBD product quality and market trends shaping patient choices and clinical perspectives. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic CbdProduct Quality[Patient Education](https://cedclinic.com/medical-cannabis-patient-education-basics/)Commercial Products Why This Matters Company founder interviews rarely provide clinical insights, but they can reveal [market trends](https://cedclinic.com/cannabis-vaporizer-market-trends-harm-reduction/) and product positioning that may influence patient choices. Understanding how CBD companies frame their products helps clinicians address patient questions about commercial formulations. Clinical Summary This appears to be a business profile of a CBD company founder rather than a clinical study or medical finding. Without access to specific product data, manufacturing standards, or clinical claims made in the interview, no meaningful clinical assessment can be provided. Company interviews typically focus on business strategy rather than therapeutic evidence. Dr. Caplan’s Take “I need to see the actual clinical claims or product specifications being discussed before offering any medical perspective. Business interviews about CBD companies don’t typically generate actionable clinical insights.” Clinical Perspective 🧠 When patients ask about specific CBD brands, focus on third-party testing certificates, dosing consistency, and whether the company makes appropriate versus inappropriate medical claims. Company founder interviews are marketing content, not clinical guidance. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Q%26A%20with%20Scott%20Mazza%2C%20Founder%20of%20Vitality%20CBD%20%7C%20citybiz%20%40drcaplan&url=https%3A//www.citybiz.co/article/834449/qa-with-scott-mazza-founder-of-vitality-cbd/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.citybiz.co/article/834449/qa-with-scott-mazza-founder-of-vitality-cbd/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Q%26A%20with%20Scott%20Mazza%2C%20Founder%20of%20Vitality%20CBD%20%7C%20citybiz%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.citybiz.co/article/834449/qa-with-scott-mazza-founder-of-vitality-cbd/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.citybiz.co/article/834449/qa-with-scott-mazza-founder-of-vitality-cbd/](https://www.citybiz.co/article/834449/qa-with-scott-mazza-founder-of-vitality-cbd/) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What are the main topics covered in this cannabis-related article?](#What_are_the_main_topics_covered_in_this_cannabis-related_article) - [Why is product quality highlighted as a key topic?](#Why_is_product_quality_highlighted_as_a_key_topic) - [What does the patient education component likely address?](#What_does_the_patient_education_component_likely_address) - [How does this information relate to commercial CBD products?](#How_does_this_information_relate_to_commercial_CBD_products) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings or policy developments are emerging and worth monitoring closely by [healthcare professionals](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). #### What are the main topics covered in this cannabis-related article? The article focuses on CBD, product quality, [patient education](https://cedclinic.com/medical-cannabis-patient-education-basics/), and commercial products. These topics suggest it addresses important considerations for both healthcare providers and patients regarding [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) in the marketplace. #### Why is product quality highlighted as a key topic? Product quality is crucial for [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) because variations in manufacturing, labeling accuracy, and contamination can significantly impact patient safety and treatment outcomes. Healthcare providers need reliable information about product standards to make appropriate recommendations. #### What does the patient education component likely address? Patient education regarding CBD typically covers proper dosing, potential interactions with medications, and how to identify quality products. This information helps patients make informed decisions and use CBD products safely under medical supervision. #### How does this information relate to commercial CBD products? The focus on commercial products suggests the article addresses the regulatory landscape and quality standards for CBD products available to consumers. This is important for clinicians who need to understand what products their patients may be using or considering. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Holistic Greens CBD Gummies Reviews: What I Found After Structured Testing – Pathologica An in-depth review of Holistic Greens CBD Gummies based on structured testing, providing insights into product quality and efficacy. Read Review Buy CBD Gummies Online: A Practical Guide for Health-Conscious Adults A practical guide to purchasing CBD gummies online, focusing on quality, safety, and informed consumer choices. Learn More [Triple Green Farms CBD Gummies Claims Evaluated – Yahoo Finance](https://cedclinic.com/cbd-gummies-male-enhancement-marketing-concerns/) Evaluation of marketing claims for Triple Green Farms CBD Gummies, highlighting clinical relevance and product standards. [Explore Analysis](https://cedclinic.com/cbd-gummies-male-enhancement-marketing-concerns/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).